Evolving landscape of PD-L2: bring new light to checkpoint immunotherapy | British Journal of Cancer
Programmed Death Ligand 2 in Cancer-Induced Immune Suppression
Programmed cell death-ligand 2: A neglected but important target in the immune response to cancer? - ScienceDirect
PD-L2 glycosylation promotes immune evasion and predicts anti-EGFR efficacy | Journal for ImmunoTherapy of Cancer
PD-1/PD-L1 inhibitors treatment in lung cance | EurekAlert!
Human PD-L2/B7-DC Antibody AF1224: R&D Systems
Programmed Death-1 Ligand 2-Mediated Regulation of the PD-L1 to PD-1 Axis Is Essential for Establishing CD4+ T Cell Immunity - ScienceDirect
PD-L2 / PDCD1LG2 / CD273 - Clone PDL2/2676 | 80380
PD-1:PD-L2 Cell-Based Inhibitor Screening Assay Kit
Programmed cell death-1/programmed cell death ligand-1 checkpoint inhibitors: differences in mechanism of action | Immunotherapy
PathPlus™ PD-L2 / PDCD1LG2 / CD273 Monoclonal Antibody Mouse | LSBio
AlphaLISA Human PD-1/PD-L2 Binding Kit, 500 Assay Points | PerkinElmer
Frontiers | The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation
PD-L1 and PD-L2 expression correlated genes in non-small-cell lung cancer | Cancer Communications | Full Text
AlphaLISA Human PD-1/PD-L2 Binding Kit, 500 Assay Points | PerkinElmer
Tissue and circulating PD-L2: moving from health and immune-mediated diseases to head and neck oncology - ScienceDirect
Role of PD‐L1 and PD‐L2 in allergic diseases and asthma - Singh - 2011 - Allergy - Wiley Online Library
PD-L2 / PDCD1LG2 / CD273 - Clone PDL2/1850 | 80380
Frontiers | The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation
PD-L1 and PD-L2 Bind to PD-1 to Inhibit T Cell Activation | Bio-Techne
CHO-K1/PD-L2 Stable Cell Line - GenScript
Evolving landscape of PD-L2: bring new light to checkpoint immunotherapy | British Journal of Cancer
PD-L2 Detection Set - Cat. No. RF16020 | ProSci
